Nat Rev Cardiol 21(2):69 Kushner RF, Ryan DH, Deanfield J, Kokkinos A, Cercato C, Wilding J et al (2025) Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial
However, you can rest assured that you will be well-cared-for and made to feel comfortable throughout the process, and you will find enjoyment in your results for years to come
Related Treatments Ready to Start Your Own Transformation Journey
Zepbound: On November 8, 2023 the FDA announced the approval of tirzepatide injections for: chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg/ m2) or greater) or overweight (body mass index of 27 kg/m2 or greater) with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in addition to a reduced calorie diet and increased physical activity. Tirzepatide for Diabetes, Weight Loss and Hypertension
Supplementary Figs
This dual-pronged strategy aims to address the multifactorial nature of metabolic dysfunction
